- (1) A licensee with an active registration status and an active United States Drug Enforcement Agency (DEA) registration to prescribe in Oregon must register with the Prescription Drug Monitoring Program established under ORS 431A.855.
- (2) New licensees with an active DEA registration must register with the Prescription Drug Monitoring Program as specified in section (1) of this rule, within 30 calendar days of Oregon licensure or DEA registration, whichever is later.
Statutory/Other Authority
ORS 677.265
Statutes/Other Implemented
ORS 677.265, ORS 431A.855 & ORS 431A.877
History
OMB 6-2020, adopt filed 04/07/2020, effective 04/07/2020